<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Volume selective proton magnetic resonance spectroscopy of brain was performed on a 1.5 T magnet in 5 patients with <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo> and compared to the results in 46 healthy children and 1 healthy adult </plain></SENT>
<SENT sid="1" pm="."><plain>Peaks of N-<z:chebi fb="9" ids="46887">acetyl</z:chebi> <z:chebi fb="0" ids="29995">aspartate</z:chebi>, <z:chebi fb="3" ids="15354">choline</z:chebi>, and <z:chebi fb="2" ids="16919">creatine</z:chebi> but not <z:chebi fb="4" ids="24996">lactate</z:chebi>, were observed in both groups on proton magnetic resonance spectroscopy </plain></SENT>
<SENT sid="2" pm="."><plain>Spectroscopy of controls revealed an increase with advancing age in the ratio of N-<z:chebi fb="9" ids="46887">acetyl</z:chebi> <z:chebi fb="0" ids="29995">aspartate</z:chebi>/<z:chebi fb="3" ids="15354">choline</z:chebi> and N-<z:chebi fb="9" ids="46887">acetyl</z:chebi> <z:chebi fb="0" ids="29995">aspartate</z:chebi>/<z:chebi fb="2" ids="16919">creatine</z:chebi> and a decrease in the <z:chebi fb="3" ids="15354">choline</z:chebi>/<z:chebi fb="2" ids="16919">creatine</z:chebi> ratio </plain></SENT>
<SENT sid="3" pm="."><plain>In patients with congenital myotonic <z:mpath ids='MPATH_554'>dystrophy</z:mpath>, the N-<z:chebi fb="9" ids="46887">acetyl</z:chebi> <z:chebi fb="0" ids="29995">aspartate</z:chebi>/<z:chebi fb="3" ids="15354">choline</z:chebi> ratio did not increase with advancing age, but the N-<z:chebi fb="9" ids="46887">acetyl</z:chebi> <z:chebi fb="0" ids="29995">aspartate</z:chebi>/<z:chebi fb="2" ids="16919">creatine</z:chebi> ratio did </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:chebi fb="3" ids="15354">choline</z:chebi>/<z:chebi fb="2" ids="16919">creatine</z:chebi> ratio decreased with advancing age, which matched the results of controls </plain></SENT>
<SENT sid="5" pm="."><plain>At any age older than 4 years, the N-<z:chebi fb="9" ids="46887">acetyl</z:chebi> <z:chebi fb="0" ids="29995">aspartate</z:chebi>/<z:chebi fb="3" ids="15354">choline</z:chebi> and N-<z:chebi fb="9" ids="46887">acetyl</z:chebi> <z:chebi fb="0" ids="29995">aspartate</z:chebi>/<z:chebi fb="2" ids="16919">creatine</z:chebi> ratios were lower in patients with congenital myotonic <z:mpath ids='MPATH_554'>dystrophy</z:mpath> than in controls </plain></SENT>
<SENT sid="6" pm="."><plain>The <z:chebi fb="3" ids="15354">choline</z:chebi>/<z:chebi fb="2" ids="16919">creatine</z:chebi> ratio did not differ between congenital myotonic <z:mpath ids='MPATH_554'>dystrophy</z:mpath> and controls </plain></SENT>
<SENT sid="7" pm="."><plain>These results suggest that in patients with congenital myotonic <z:mpath ids='MPATH_554'>dystrophy</z:mpath> N-<z:chebi fb="9" ids="46887">acetyl</z:chebi> <z:chebi fb="0" ids="29995">aspartate</z:chebi> decreases and there exists a <z:e sem="disease" ids="C0008073" disease_type="Mental or Behavioral Dysfunction" abbrv="">developmental disorder</z:e> of neurons in brain </plain></SENT>
</text></document>